跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,153 条关于
“FH-RCC”
全部
5,153
临床试验
4,392
药物
429
机构
22
资讯
310
去年
Lenvatinib-Tislelizumab Combo Shows Promising 93% Response Rate in Rare Hereditary Kidney Cancer
2年前
Lenvatinib and Pembrolizumab Combination Shows Promise in Non-Clear Cell Renal Cell Carcinoma Subtypes
去年
SABR Shows Promise in Renal Cell Carcinoma Management
去年
Advancements in Renal Cell Carcinoma Treatment: Immunotherapy Combinations and Personalized Approaches
去年
SUO 2024: Update on Neoadjuvant Therapy Trials in RCC
2年前
Cabozantinib/Nivolumab Shows Consistent Benefits in RCC, Except for Favorable-Risk Group
去年
Novel Therapies Show Promise in Reshaping Frontline Metastatic RCC Treatment Landscape
2年前
CBM588 Shows Promise in Improving Outcomes for Metastatic Renal Cell Carcinoma
2年前
Abemaciclib Monotherapy Fails to Show Efficacy in Advanced Renal Cell Carcinoma
去年
Tivozanib Monotherapy Shows Superior PFS Compared to Combination Therapy in Post-ICI Renal Cell Carcinoma
第 1 页,共 31 页
上一页
下一页